- Report
- March 2025
- 185 Pages
Global
From €3972EUR$4,500USD£3,430GBP
- Report
- March 2025
- 180 Pages
Global
From €3972EUR$4,500USD£3,430GBP
- Report
- February 2025
- 182 Pages
Global
From €3972EUR$4,500USD£3,430GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3089EUR$3,500USD£2,668GBP
- Report
- September 2024
- 82 Pages
Japan
From €3089EUR$3,500USD£2,668GBP
- Report
- February 2024
- 185 Pages
Global
From €3972EUR$4,500USD£3,430GBP
- Report
- October 2023
- 128 Pages
North America
From €3531EUR$4,000USD£3,049GBP
- Report
- October 2023
- 178 Pages
Global
From €3972EUR$4,500USD£3,430GBP
- Report
- July 2024
- 100 Pages
Global
From €3310EUR$3,750USD£2,858GBP
- Report
- July 2024
- 150 Pages
Global
From €3310EUR$3,750USD£2,858GBP
- Report
- July 2024
- 100 Pages
Global
From €3310EUR$3,750USD£2,858GBP
- Report
- February 2024
- 115 Pages
Global
From €4193EUR$4,750USD£3,621GBP
- Report
- June 2025
- 250 Pages
India
From €2462EUR$2,789USD£2,126GBP
- Report
- June 2025
- 250 Pages
Japan
From €2462EUR$2,789USD£2,126GBP
- Report
- October 2024
- 200 Pages
Global
From €4368EUR$4,949USD£3,772GBP
- Report
- October 2024
- 200 Pages
Global
From €4368EUR$4,949USD£3,772GBP
- Report
- August 2024
- 200 Pages
Global
From €3415EUR$3,869USD£2,949GBP
- Report
- December 2023
- 160 Pages
United States
From €2462EUR$2,789USD£2,126GBP
- Report
- May 2023
- 147 Pages
Global
From €4368EUR$4,949USD£3,772GBP
- Report
- April 2023
- 147 Pages
Global
From €4368EUR$4,949USD£3,772GBP

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise.
The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more